Home
Conditions
Glomerulonephritis, IGA

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

203 public trials 59 recruiting studies

Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Not yet recruiting

Evaluate the Efficacy and Safety of NTQ5082 Capsules in Patients With Primary IgA Nephropathy

NCT06982040

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases

NCT06774664

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: The First Affiliated Hospital of Baotou Medical College Baotou, China

Beijing Tsinghua Changgung Hospital Beijing, China

Peking University First Hospital Beijing, China

Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital Chengdu, China

View all 20 locations

View Trial Details

Not yet recruiting

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

NCT06690359

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

NCT06687174

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

NCT05517980

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +8 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

NCT06635772

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Peking University First Hospital Beijing, China

View Trial Details

Not yet recruiting

Effect of Finerenone in IgA Nephropathy

NCT06580288

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Efficacy and Safety of Probiotics Combined With Enteric-coated Budesonide Capsules in Patients With Primary IgA Nephropathy

NCT06528015

Conditions: Autoimmune Diseases, Budesonide, Female Urogenital Diseases, +10 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China

View Trial Details

Not yet recruiting

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Enrolling by invitation

The MIMIGA Study is a Randomized, Double-blind, Placebo-controlled Crossover Trial Evaluating the Safety and Efficacy of SCFA vs. Placebo. Administered Orally Once Daily With Standard Care, it Aims to Prevent CKD Progression in Biopsy-proven IgA Nephropathy by Modulating the Gut Microbiome.

NCT07750249

Conditions: Autoimmune Diseases, Chronic Disease, Disease Attributes, +15 more
Locations: University Hospital Martin Martin, Slovakia

View Trial Details

Glomerulonephritis, IGA

Glomerulonephritis, IGA trial results

Related conditions